Clinical Trials Logo

Filter by:
NCT ID: NCT04659746 Completed - Quality of Life Clinical Trials

MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay

MejoraCare_P
Start date: December 9, 2020
Phase: N/A
Study type: Interventional

MejoraCare-Paraguay main objective is to test a mHealth solution (MejoraCare app) to be used for the education and empowerment of chronic patients (COPD, cancer, diabetes, heart disease. hypertension, etc.), and for supporting healthcare professionals to monitor and better understand patients' evolution during the COVID-19 outbreak (MejoraCare dashboard). This mHealth solution is built upon the Adhera platform, which has already been validated in other therapeutic areas such as smoking cessation. MejoraCare is expected to raise awareness, educate and empower chronic patients, promoting behavioral changes towards adhering to healthier lifestyles thus reducing the risk of COVID-19 infection while providing emotional regulation support aiming at improving their mental health, quality of life, and emotional well-being.

NCT ID: NCT04538287 Completed - Conduction Defect Clinical Trials

AtaCor Subcostal Temporary Extravascular Pacing III Study

STEP III
Start date: October 3, 2020
Phase: N/A
Study type: Interventional

Third in-human study for the AtaCor Extravascular (EV) Temporary Pacing Lead System to collect initial safety and performance data for the latest AtaCor System. The objective of the study is to generate safety and performance data of the latest AtaCor EV Temporary Pacing Lead System 1) to support the development a future pivotal study with an indication limited to a maximum of 7 days, and 2) to obtain early clinical data for future research related to longer-term use.

NCT ID: NCT04485520 Completed - Dental Plaque Clinical Trials

Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans

Start date: September 21, 2017
Phase: N/A
Study type: Interventional

Papaya has effects on oral pathogenic microorganisms, it also has anticoagulant quality, amebicidal action, antimicrobial, bacteriostatic and antifungal activity on different bacteria, especially on Streptococcus mutans, this can be exploited in the dental area. The objective of the study was to determine the efficacy of Carica Papaya peel extract (suckling) as an inhibitor of Streptococcus Mutans in students of the dental faculty of the National University of Caaguazú in 2018.

NCT ID: NCT04410666 Completed - Dental Plaque Clinical Trials

Antibacterial Effect of the Infusion of Green Tea Used as a Mouthwash on Saliva and Bacterial Plaque

Start date: August 21, 2016
Phase: N/A
Study type: Interventional

Given that the participation of oral microorganisms in the development of the most prevalent pathologies of the oral cavity is unquestionable, efforts have been made to create agents that allow controlling these bacteria. The objective of this work was to analyze the antibacterial effect of green tea infusion used as a mouthwash on saliva and bacterial plaque. The green tea infusion was prepared at 13% at approximately 90 ° C, being the same applied to 14 participants from the 1st to the 5th grade (experimental group); and to other 14 participants the placebo was applied (control group). The antibacterial effect was determined by counting the colony forming units (CFU) in the cultures of samples of bacterial plaque and saliva, taken before the application of the infusion and immediately after.

NCT ID: NCT04407325 Recruiting - Radiography Clinical Trials

Tuberculosis Screening in Paraguayan Prisons

Prinose
Start date: October 18, 2021
Phase: N/A
Study type: Interventional

Two diagnostic tools for TB screening in high risk groups need additional assessment: the AeoNoseā„¢, an 'electronic nose device' for breath sampling, and digital chest X-ray (CXR) with computer aided detection with CAD4TB® software. This study will systematically screen prisoners and its' employees for TB, test the diagnostic performance of AeoNoseā„¢ and CAD4TB (both individually and together) as a TB screening tool and and establish Mycobacterium tuberculosis epidemiology in Paraguayan prisons.

NCT ID: NCT04374929 Completed - Conduction Defect Clinical Trials

Subcostal Temporary Extracardiac Pacing II Study

STEP II
Start date: July 28, 2020
Phase: N/A
Study type: Interventional

Up to 12 subjects will be enrolled (up to 8 undergoing an AtaCor Temporary Pacing System procedure) in order to evaluate initial safety and performance of the AtaCor Temporary Pacing System when used with three (3) strategies for stabilizing AtaCor Temporary Pacing System electrical measurements over a two (2) to seven (7) day period. The three treatments are (1) Negative Pressure Wound Therapy, (2) Anti-Inflammatory Glucocorticoid and (3) increased electrode spacing. A control arm with no additional treatment is also included. Safety will be evaluated through analysis of all Adverse Events. Performance will be evaluated through (1) the incidence of successful StealthTrac Lead placement using the MACH I Delivery Tool, (2) electrical performance measurements, such as pacing capture thresholds, sensed R-wave amplitudes, pacing impedance and skeletal muscle stimulation. Appropriate sensing and pacing capture will be ascertained from ECG Holter Monitor recordings during periods of in-hospital ambulation.

NCT ID: NCT04281940 Active, not recruiting - Clinical trials for Mitral Valve Regurgitation

Chordal Repair for Transcatheter Mitral Valve Repair (TMVr)

Start date: March 18, 2022
Phase: N/A
Study type: Interventional

A multi-center evaluation of the Pipeline chordal repair system for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve repair.

NCT ID: NCT04232774 Completed - Clinical trials for Type 2 Diabetes Mellitus With Circulatory Complciation

Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

NECTAR
Start date: November 4, 2019
Phase: N/A
Study type: Interventional

The study is to assess the safety and feasibility of chemical denervation of multiple artery beds for the treatment of Type 2 diabetes (T2DM) and its comorbidities.

NCT ID: NCT04141098 Active, not recruiting - Clinical trials for Degenerative Disc Disease

Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy

LOPAIN1
Start date: October 10, 2019
Phase: N/A
Study type: Interventional

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device deployed to reduce chronic low back pain.

NCT ID: NCT04138394 Recruiting - Shock Clinical Trials

VItamin C in Thermal injuRY: The VICToRY Trial

VICToRY
Start date: July 24, 2020
Phase: Phase 3
Study type: Interventional

This study aims to show that giving high dose, intravenous vitamin C in addition to standard care to burned critically ill patients will be associated with less organ dysfunction, improved survival and a quicker rate of recovery. In this study, all patients will receive standard care and of the patients will also receive high dose intravenous vitamin C, while the other half of patients will receive placebo.